After Embryo Mi Up Allegation, Govt Tightens Rules On Sale Of IVF Lab Supplies
After Embryo Mi Up Allegation, Govt Tightens Rules On Sale Of IVF Lab Supplies Reported By, Last Updated: June 27, 2026, 09:00 IST The advisory
After Embryo Mi Up Allegation, Govt Tightens Rules On Sale Of IVF Lab Supplies Reported By, Last Updated: June 27, 2026, 09:00 IST The advisory covers specialised liquids, chemicals and other laboratory supplies used to grow, preserve and handle eggs and embryos during IVF treatment. Rapid Read Specialised laboratory supplies are used to grow, preserve and handle eggs and embryos during IVF treatment. (AI-generated image) The country’s apex drug regulatory agency has tightened rules governing the sale of key products used in IVF treatment, saying they should be supplied only to registered fertility clinics, News18 has learnt. The move comes at a time when fertility centres are under scrutiny following allegations by a Gurugram couple — now parents of twin girls — that their embryos were mixed up at a South Delhi-based IVF clinic. The products covered under the new advisory are not medicines taken by patients. They are specialised liquids, chemicals and other laboratory consumables used to grow, preserve and handle eggs and embryos during IVF treatment. The objective of the government’s move is to ensure that these products do not reach unregistered centres, as doing so could put patients at risk. Government Says IVF Supplies Were Reaching Unregistered Centres In a circular issued on June 23, the Central Drugs Standard Control Organisation (CDSCO) said these products are regulated as medical devices and require licences for import or manufacture.
According to the circular, “The media, reagents, etc., intended for use in Assisted Reproductive Technology such as In-Vitro Fertilisation, Cryopreservation, etc., are also covered under the purview of the said rules and a license is required to import or manufacture such products under Medical Devices Rules, 2017." The regulator said it had found that these products were being supplied beyond licensed fertility centres. It stated, “It has been brought to the notice of this office that Assisted Reproductive Technology Media etc. are being supplied to facilities other than those that are registered under the said Acts, thereby posing risk to patient health and welfare." To stop this, the CDSCO has asked manufacturers, importers and suppliers to sell these products only to clinics and banks registered under India’s Assisted Reproductive Technology and surrogacy laws. The circular states, “In light of the above, it is hereby informed that all the stakeholders are requested to ensure that the supply of such products shall be carried out to the centres that are registered under the Assisted Reproductive Technology (Regulation) Act, 2021 and the Surrogacy (Regulation) Act, 2021, to safeguard ethical reproductive healthcare practices in India." Why Do Doctors Say This Matters? While patients may never see these products, doctors told News18 that they are essential to every IVF procedure.
The BriefWire